https://www.sciencedaily.com/news/health_medicine/add_and_adhd/ Read the latest medical research on ADD, ADHD and related attention deficit disorders. Find information on ADD and ADHD tests, diagnosis methods, ADHD drugs and new approaches to ADHD treatment. en-us Sun, 15 Mar 2026 07:13:01 EDT Sun, 15 Mar 2026 07:13:01 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/add_and_adhd/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/01/260124073920.htm A large, decades-long study suggests that signs of ADHD in childhood may have consequences that extend well beyond school and behavior. Researchers followed nearly 11,000 people from childhood into midlife and found that those with strong ADHD traits at age 10 were more likely to experience multiple physical health problems and health-related disability by their mid-40s. Sat, 24 Jan 2026 07:39:20 EST https://www.sciencedaily.com/releases/2026/01/260124073920.htm https://www.sciencedaily.com/releases/2025/12/251225235942.htm ADHD stimulants appear to work less by sharpening focus and more by waking up the brain. Brain scans revealed that these medications activate reward and alertness systems, helping children stay interested in tasks they would normally avoid. The drugs even reversed brain patterns linked to sleep deprivation. Researchers say this could complicate ADHD diagnoses if poor sleep is the real underlying problem. Thu, 25 Dec 2025 23:59:42 EST https://www.sciencedaily.com/releases/2025/12/251225235942.htm https://www.sciencedaily.com/releases/2025/12/251223084852.htm New research reveals a brighter side of ADHD, showing that adults who recognize and use their strengths feel happier, healthier, and less stressed. People with ADHD were more likely to identify traits like creativity, humor, and hyperfocus as personal strengths. Across the board, using these strengths was linked to better quality of life and fewer mental health symptoms. The study suggests that embracing strengths could be a game-changer for ADHD support. Wed, 31 Dec 2025 10:51:21 EST https://www.sciencedaily.com/releases/2025/12/251223084852.htm https://www.sciencedaily.com/releases/2025/09/250915202839.htm Preschoolers with ADHD are often given medication right after diagnosis, against medical guidelines that recommend starting with behavioral therapy. Limited access to therapy and physician pressures drive early prescribing, despite risks and reduced effectiveness in young children. Tue, 16 Sep 2025 05:10:52 EDT https://www.sciencedaily.com/releases/2025/09/250915202839.htm https://www.sciencedaily.com/releases/2025/05/250514180742.htm A recent study reveals that the average duration of ADHD medication for children and adolescents is more than three years. However, reliable, controlled data on the safety of marketed ADHD medicines in children are available for only one year of follow-up. Wed, 14 May 2025 18:07:42 EDT https://www.sciencedaily.com/releases/2025/05/250514180742.htm https://www.sciencedaily.com/releases/2025/03/250305164522.htm A study of people who started ADHD stimulant treatment via telehealth vs in-person visits shows no difference in risk of new substance use disorders except for young adults age 26-34. Wed, 05 Mar 2025 16:45:22 EST https://www.sciencedaily.com/releases/2025/03/250305164522.htm https://www.sciencedaily.com/releases/2025/01/250123110251.htm Adults who have been diagnosed with attention deficit hyperactivity disorder (ADHD) may be living shorter lives than they should, finds a new study. Thu, 23 Jan 2025 11:02:51 EST https://www.sciencedaily.com/releases/2025/01/250123110251.htm https://www.sciencedaily.com/releases/2024/10/241014210502.htm Attention deficit/hyperactivity disorder -- also known as ADHD -- is typically thought of as a childhood condition. But more adults are realizing that their struggles with attention, focus and restlessness could in fact be undiagnosed ADHD, thanks in large part to trending social media videos racking up millions of views. A new national survey of 1,000 American adults finds that 25% of adults now suspect they may have undiagnosed ADHD. But what worries mental health experts is that only 13% of survey respondents have shared their suspicions with their doctor. Mon, 14 Oct 2024 21:05:02 EDT https://www.sciencedaily.com/releases/2024/10/241014210502.htm https://www.sciencedaily.com/releases/2024/09/240902200800.htm A UK survey has found huge variation in treatment for ADHD, highlighting the struggle many young adults face once they turn 18. Researchers have warned that the current system is failing many young adults as they transition from children's to adult's services -- suddenly finding themselves unable to access treatment because services do not link up effectively. Mon, 02 Sep 2024 20:08:00 EDT https://www.sciencedaily.com/releases/2024/09/240902200800.htm https://www.sciencedaily.com/releases/2024/08/240808115236.htm Research has found that medications play an important role in improving the quality of life of people with ADHD, but the authors suggest more support -- in addition to medications -- is needed. Thu, 08 Aug 2024 11:52:36 EDT https://www.sciencedaily.com/releases/2024/08/240808115236.htm https://www.sciencedaily.com/releases/2024/05/240523112611.htm An exploration into the national U.S. dataset on children ever diagnosed with ADHD has revealed an 'ongoing and ever-expanding' public health issue. Thu, 23 May 2024 11:26:11 EDT https://www.sciencedaily.com/releases/2024/05/240523112611.htm https://www.sciencedaily.com/releases/2023/11/231108115119.htm Results from a new clinical trial suggest that a group of brain regions known as the 'salience network' is activated after a drug is taken intravenously, but not when that same drug is taken orally. When drugs enter the brain quickly, such as through injection or smoking, they are more addictive than when they enter the brain more slowly, such as when they are taken orally. However, the brain circuits underlying these differences are not well understood. This study offers new information that helps explain what may be causing this difference. Wed, 08 Nov 2023 11:51:19 EST https://www.sciencedaily.com/releases/2023/11/231108115119.htm https://www.sciencedaily.com/releases/2023/10/231004132403.htm In a study on the prevalence of attention-deficit/hyperactivity disorder (ADHD) and its association with crash risk among older adult drivers, researchers found that older adult drivers with ADHD are at a significantly elevated crash risk compared with their counterparts without ADHD. Outcomes included hard- braking events, and self-reported traffic ticket events, and vehicular crashes. Until now research on ADHD and driving safety was largely limited to children and young adults, and few studies assessed the association of ADHD with crash risk among older adults. Wed, 04 Oct 2023 13:24:03 EDT https://www.sciencedaily.com/releases/2023/10/231004132403.htm https://www.sciencedaily.com/releases/2023/09/230918105105.htm Researchers investigated the characteristics and trends of out-of-hospital ADHD medication errors among people younger than 20 years old reported to U.S. poison centers from 2000 through 2021. Mon, 18 Sep 2023 10:51:05 EDT https://www.sciencedaily.com/releases/2023/09/230918105105.htm https://www.sciencedaily.com/releases/2023/02/230209114741.htm A large international study has identified 27 loci in the human genome with genetic variants that increase the risk of ADHD. This is more than twice as many as previous studies have found. Thu, 09 Feb 2023 11:47:41 EST https://www.sciencedaily.com/releases/2023/02/230209114741.htm https://www.sciencedaily.com/releases/2023/01/230116112600.htm On Blue Monday -- supposedly the gloomiest day of the year -- a study shows adults with high levels of attention-deficit hyperactivity disorder (ADHD) symptoms are more likely to experience anxiety and depression than adults with high levels of autistic traits. Mon, 16 Jan 2023 11:26:00 EST https://www.sciencedaily.com/releases/2023/01/230116112600.htm https://www.sciencedaily.com/releases/2022/12/221208123533.htm For decades, doctors have treated kids with attention-deficit/hyperactivity disorder (ADHD) with methylphenidate, a stimulant drug sold as Ritalin and Concerta, making it one of the most widely prescribed medications aimed at the central nervous system. One might expect that researchers would know how methylphenidate works in the brain by now, but little is known about the drug's mechanism of action. Now, a new study seeks to close this gap and understand how methylphenidate interacts with cognitive control networks and attentional behavior. Thu, 08 Dec 2022 12:35:33 EST https://www.sciencedaily.com/releases/2022/12/221208123533.htm https://www.sciencedaily.com/releases/2022/12/221208085834.htm Genetic predisposition to attention-deficit/hyperactivity disorder can predict cognitive decline and Alzheimer's disease later in life, study finds. Thu, 08 Dec 2022 08:58:34 EST https://www.sciencedaily.com/releases/2022/12/221208085834.htm https://www.sciencedaily.com/releases/2022/05/220519115333.htm Here's another good reason for children with attention deficit hyperactivity disorder (ADHD) to eat their fruits and vegetables: It may help reduce inattention issues, a new study suggests. Thu, 19 May 2022 11:53:33 EDT https://www.sciencedaily.com/releases/2022/05/220519115333.htm https://www.sciencedaily.com/releases/2022/04/220429144909.htm Researchers found animals that had taken methylphenidate performed better on a visual task of attention, and that the improvement happened exactly when that same metric of neuron activity shifted. Fri, 29 Apr 2022 14:49:09 EDT https://www.sciencedaily.com/releases/2022/04/220429144909.htm https://www.sciencedaily.com/releases/2021/08/210813100258.htm Most children diagnosed with attention deficit hyperactive disorder (ADHD) don't outgrow the disorder, as widely thought. It manifests itself in adulthood in different ways and waxes and wanes over a lifetime, according to a new study. Fri, 13 Aug 2021 10:02:58 EDT https://www.sciencedaily.com/releases/2021/08/210813100258.htm https://www.sciencedaily.com/releases/2021/01/210127171838.htm A new study has identified how specific communication among different brain regions, known as brain connectivity, can serve as a biomarker for attention deficit hyperactivity disorder (ADHD). Wed, 27 Jan 2021 17:18:38 EST https://www.sciencedaily.com/releases/2021/01/210127171838.htm https://www.sciencedaily.com/releases/2020/12/201230094226.htm The introduction of computer simulation to the identification of symptoms in children with attention deficit/hyperactivity disorder (ADHD) has potential to provide an additional objective tool to gauge the presence and severity of behavioral problems, researchers suggest. Wed, 30 Dec 2020 09:42:26 EST https://www.sciencedaily.com/releases/2020/12/201230094226.htm https://www.sciencedaily.com/releases/2020/08/200818142135.htm A new study reports that the risk of being involved in car crashes increases for those diagnosed with attention-deficit/hyperactivity disorder (ADHD). The study looked specifically at the rate of car crashes by adulthood, which was 1.45 times higher in those with a childhood history of ADHD compared to adults with no ADHD. Tue, 18 Aug 2020 14:21:35 EDT https://www.sciencedaily.com/releases/2020/08/200818142135.htm https://www.sciencedaily.com/releases/2020/02/200203104447.htm Children diagnosed with ADHD inconsistently take their prescribed medication, going without treatment 40 per cent of the time, a new study has found. Mon, 03 Feb 2020 10:44:47 EST https://www.sciencedaily.com/releases/2020/02/200203104447.htm https://www.sciencedaily.com/releases/2020/01/200117100257.htm Researchers have identified how certain areas of the human brain respond to methylphenidate -- a stimulant drug which is used to treat symptoms of ADHD. The work may help researchers understand the precise mechanism of the drug and ultimately develop more targeted medicines for the condition. Fri, 17 Jan 2020 10:02:57 EST https://www.sciencedaily.com/releases/2020/01/200117100257.htm https://www.sciencedaily.com/releases/2019/10/191030100049.htm Researchers have investigated the actions of the drug in rats. Using dopamine cell recordings, electrochemical monitoring and computer modeling, they discovered a type of feedback loop that modulates dopamine levels in the rats' brains in response to the drug. This regulatory process may shed light on methylphenidate's therapeutic properties in ADHD. Wed, 30 Oct 2019 10:00:49 EDT https://www.sciencedaily.com/releases/2019/10/191030100049.htm https://www.sciencedaily.com/releases/2019/05/190520081922.htm Teen drivers diagnosed with attention-deficit hyperactivity disorder (ADHD) are significantly more likely to crash, be issued traffic and moving violations, and engage in risky driving behaviors than their peers without ADHD. Mon, 20 May 2019 08:19:22 EDT https://www.sciencedaily.com/releases/2019/05/190520081922.htm https://www.sciencedaily.com/releases/2019/03/190320171704.htm Researchers evaluated the two most common ADHD treatments and found that, although the risk of psychosis is low, it is greater for patients who are taking amphetamines than for those taking methylphenidates. Wed, 20 Mar 2019 17:17:04 EDT https://www.sciencedaily.com/releases/2019/03/190320171704.htm https://www.sciencedaily.com/releases/2019/02/190219091615.htm A pair of new studies has provided new insight into the challenges faced by children on the autism spectrum who exhibit symptoms of attention deficit/hyperactivity disorder (ADHD). According to the findings, these children have difficulty with adaptive behavior, a key measure of independence. Tue, 19 Feb 2019 09:16:15 EST https://www.sciencedaily.com/releases/2019/02/190219091615.htm https://www.sciencedaily.com/releases/2019/01/190116090630.htm A study finds a surprising response to cocaine in a novel strain of mutant mice -- they failed to show hyperactivity seen in normal mice when given cocaine and didn't run around. In other tests, they still found cocaine appealing, but displayed an inability to shake the memory of cocaine's actions when the drug was no longer administered. The key change that blocks cocaine's stimulant effects in these mice is serotonin, not dopamine, which is responsible for producing a high. Wed, 16 Jan 2019 09:06:30 EST https://www.sciencedaily.com/releases/2019/01/190116090630.htm https://www.sciencedaily.com/releases/2018/11/181130153852.htm African-American children often are reported by parents and teachers to display behaviors of ADHD at a higher rate than children from other racial and ethnic groups. For the first time, researchers have found that African-American mothers in a study rated boys as displaying more frequent ADHD symptoms than Caucasian mothers did, regardless of child race. Fri, 30 Nov 2018 15:38:52 EST https://www.sciencedaily.com/releases/2018/11/181130153852.htm https://www.sciencedaily.com/releases/2018/11/181128182138.htm Children who enter elementary school younger than their peers are more likely to be diagnosed with ADHD. Children born in August in states with a Sept. 1 cutoff birth date for school enrollment have a 30 percent higher risk for ADHD diagnosis than peers born in September, which may reflect over-diagnosis. Wed, 28 Nov 2018 18:21:38 EST https://www.sciencedaily.com/releases/2018/11/181128182138.htm https://www.sciencedaily.com/releases/2018/11/181128115024.htm An international collaboration has for the first time identified genetic variants which increase the risk of ADHD. The new findings provide a completely new insight into the biology behind ADHD. Wed, 28 Nov 2018 11:50:24 EST https://www.sciencedaily.com/releases/2018/11/181128115024.htm https://www.sciencedaily.com/releases/2018/09/180912081217.htm Researchers have found that ADHD patients had an increased risk of developing Parkinson's and Parkinson-like diseases than individuals with no ADHD history. Wed, 12 Sep 2018 08:12:17 EDT https://www.sciencedaily.com/releases/2018/09/180912081217.htm https://www.sciencedaily.com/releases/2018/08/180807192845.htm Study includes 133 double-blind randomized controlled trials with data from more than 14,000 children and adolescents and 10,000 adults. Tue, 07 Aug 2018 19:28:45 EDT https://www.sciencedaily.com/releases/2018/08/180807192845.htm https://www.sciencedaily.com/releases/2018/07/180728083553.htm Stimulant medications are an effective treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). In the classroom, parents and teachers say that medications like methylphenidate (MPH) can reduce symptoms and improve behavior. Although stimulants have been in use for decades to treat ADHD in school-aged children, just how they work hasn't been clear. But the results of a new study are filling in critical gaps about the role of improved cognitive functions. Sat, 28 Jul 2018 08:35:53 EDT https://www.sciencedaily.com/releases/2018/07/180728083553.htm https://www.sciencedaily.com/releases/2018/04/180402160613.htm Rising drug prices have gotten a lot of attention lately, but the actual cost of prescription medications is more than just the bill. Researchers estimate that illness and death resulting from non-optimized medication therapy costs $528.4 billion annually, equivalent to 16 percent of total U.S. health care expenditures in 2016. Mon, 02 Apr 2018 16:06:13 EDT https://www.sciencedaily.com/releases/2018/04/180402160613.htm https://www.sciencedaily.com/releases/2018/01/180102153212.htm Attention-deficit/hyperactivity disorder (ADHD) increases the risk of subsequent sexually transmitted infections (STIs) among adolescent and young adult populations by about three times, reports a new study. Tue, 02 Jan 2018 15:32:12 EST https://www.sciencedaily.com/releases/2018/01/180102153212.htm https://www.sciencedaily.com/releases/2017/12/171213143658.htm A new study leverages data from multiple large cohorts to define and quantify what, if any, increased risk may be posed by taking the most commonly used ADHD medications. The team found that one medication, methylphenidate, increased risk of heart defects by a small amount while another medication, amphetamines, did not. Wed, 13 Dec 2017 14:36:58 EST https://www.sciencedaily.com/releases/2017/12/171213143658.htm https://www.sciencedaily.com/releases/2017/09/170904093443.htm Around 75 percent of children and adults with attention deficit hyperactivity disorder (ADHD) also have sleep problems, but until now these have been thought to be separate issues. Now a in a pulling together of the latest research, Scientists are proposing of a new theory which says that much of ADHD may in fact be a problem associated with lack of regular circadian sleep. Mon, 04 Sep 2017 09:34:43 EDT https://www.sciencedaily.com/releases/2017/09/170904093443.htm https://www.sciencedaily.com/releases/2017/07/170712201249.htm The use of medication to treat attention deficient hyperactivity disorder is linked to significantly lower risk for substance use problems in adolescents and adults with ADHD, according to a new study. Wed, 12 Jul 2017 20:12:49 EDT https://www.sciencedaily.com/releases/2017/07/170712201249.htm https://www.sciencedaily.com/releases/2017/05/170524162341.htm Using volunteers to train parents concerned about attention deficit/hyperactivity disorder (ADHD) in their children can improve capacity to meet increasing ADHD treatment needs, finds a new study. Wed, 24 May 2017 16:23:41 EDT https://www.sciencedaily.com/releases/2017/05/170524162341.htm https://www.sciencedaily.com/releases/2017/05/170515154802.htm New research has explored the potential side effects of the stimulant drug Ritalin on those without ADHD showed changes in brain chemistry associated with risk-taking behavior, sleep disruption and other undesirable effects. Mon, 15 May 2017 15:48:02 EDT https://www.sciencedaily.com/releases/2017/05/170515154802.htm https://www.sciencedaily.com/releases/2017/05/170510132007.htm In a study of more than 2.3 million patients in the United States with attention-deficit/hyperactivity disorder (ADHD), rates of motor vehicle crashes (MVCs) were lower when they had received their medication, according to a new article. Wed, 10 May 2017 13:20:07 EDT https://www.sciencedaily.com/releases/2017/05/170510132007.htm https://www.sciencedaily.com/releases/2017/03/170306091726.htm The first study to both show and measure the effects of cognitive-enhancing drugs such as modafinil, methylphenidate (best known under the trade name Ritalin), and caffeine, on chess play is being published. Research shows significant cognitive improvements for modafinil and methylphenidate, and may influence how these drugs are used off-label in a range of activities. Mon, 06 Mar 2017 09:17:26 EST https://www.sciencedaily.com/releases/2017/03/170306091726.htm https://www.sciencedaily.com/releases/2017/02/170216105919.htm Largest imaging study of ADHD to date identifies differences in five regions of the brain, with greatest differences seen in children rather than adults. Thu, 16 Feb 2017 10:59:19 EST https://www.sciencedaily.com/releases/2017/02/170216105919.htm https://www.sciencedaily.com/releases/2016/10/161027143526.htm Pediatric researchers report that children with ASD may mistakenly be diagnosed with ADHD because they have autism-related social impairments rather than problems with attention. This is important for understanding what are the right services and treatments for a child. Thu, 27 Oct 2016 14:35:26 EDT https://www.sciencedaily.com/releases/2016/10/161027143526.htm https://www.sciencedaily.com/releases/2016/10/161025125635.htm The use of general anesthesia for surgery has not changed fundamentally since it was first introduced 170 years ago. Patients are still left to come around in their own time following withdrawal of the drug. However, some patients can take a considerable amount of time to wake up, creating a line up of problems. Now researchers have moved a step closer to a treatment to rapidly awaken patients after administration of a general anesthetic, following a study of the mechanism that allows people to regain consciousness. Tue, 25 Oct 2016 12:56:35 EDT https://www.sciencedaily.com/releases/2016/10/161025125635.htm https://www.sciencedaily.com/releases/2016/10/161013103134.htm Attention-deficit hyperactivity disorder (ADHD) is a very common condition diagnosed mainly in children. According to the Centers for Disease Control and Prevention (CDC), 6.4 million children between four and 17 years of age have been diagnosed with ADHD as of 2011. Thu, 13 Oct 2016 10:31:34 EDT https://www.sciencedaily.com/releases/2016/10/161013103134.htm https://www.sciencedaily.com/releases/2016/10/161011130010.htm Children who experience family and environmental stressors, and traumatic experiences, such as poverty, mental illness and exposure to violence, are more likely to be diagnosed with Attention Deficit/Hyperactivity Disorder (ADHD), say researchers. Tue, 11 Oct 2016 13:00:10 EDT https://www.sciencedaily.com/releases/2016/10/161011130010.htm https://www.sciencedaily.com/releases/2016/10/161004150822.htm Girls with attention deficit hyperactivity disorder are at higher risk than girls without ADHD for multiple mental disorders that often lead to cascading problems such as abusive relationships, teenage pregnancies, poor grades and drug abuse, psychologists report. Tue, 04 Oct 2016 15:08:22 EDT https://www.sciencedaily.com/releases/2016/10/161004150822.htm https://www.sciencedaily.com/releases/2016/08/160801093232.htm Three studies report that combining two standard medications could lead to greater clinical improvements for children with attention-deficit/hyperactivity disorder (ADHD) than either ADHD therapy alone. At present, studies show that the use of several ADHD medications result in significant reductions in ADHD symptoms. However, so far there is no conclusive evidence that these standard drug treatments also improve long-term academic, social, and clinical outcomes. Mon, 01 Aug 2016 09:32:32 EDT https://www.sciencedaily.com/releases/2016/08/160801093232.htm https://www.sciencedaily.com/releases/2016/07/160727111045.htm New research provides some of the first evidence that medications taken by millions of American children to treat attention-deficit/hyperactivity disorder offer long-term benefits. Wed, 27 Jul 2016 11:10:45 EDT https://www.sciencedaily.com/releases/2016/07/160727111045.htm https://www.sciencedaily.com/releases/2016/07/160726094107.htm As cases of ADHD continue to rise among US children, pediatricians at busy community practices are getting an assist from a web-based technology to improve the quality of ADHD care and patient outcomes. A multi-institutional study reports that a new web-based software program is helping reduce ADHD behavioral symptoms in children receiving care at community pediatric practices by coordinating care and ensuring patients get the most effective ADHD medications. Tue, 26 Jul 2016 09:41:07 EDT https://www.sciencedaily.com/releases/2016/07/160726094107.htm https://www.sciencedaily.com/releases/2016/06/160614083350.htm The tendency to treat childhood hyperactivity (ADHD) with drugs may have reached a plateau in the UK, following a steep rise in the number of prescriptions for these medicines over the past 20 years, reveals research. Tue, 14 Jun 2016 08:33:50 EDT https://www.sciencedaily.com/releases/2016/06/160614083350.htm https://www.sciencedaily.com/releases/2016/06/160608112938.htm Youth who take Ritalin, Adderall or other stimulant medications for ADHD over an extended period of time early in life are no more at risk for substance abuse in later adolescence than teens without ADHD, according to a new study. Wed, 08 Jun 2016 11:29:38 EDT https://www.sciencedaily.com/releases/2016/06/160608112938.htm https://www.sciencedaily.com/releases/2016/05/160531222134.htm Use of methylphenidate in children and young people with ADHD is associated with a slightly increased risk of abnormal heart rhythm (arrhythmia) shortly after the start of treatment, suggests new research. Tue, 31 May 2016 22:21:34 EDT https://www.sciencedaily.com/releases/2016/05/160531222134.htm https://www.sciencedaily.com/releases/2016/05/160518120107.htm While it is well established that childhood ADHD may continue into adulthood, new research suggests that for some people the disorder does not emerge until after childhood. Wed, 18 May 2016 12:01:07 EDT https://www.sciencedaily.com/releases/2016/05/160518120107.htm https://www.sciencedaily.com/releases/2016/05/160502131413.htm Children with Attention Deficit and Hyperactivity Disorder follow fewer healthy lifestyle behaviors than non-ADHD youth. ADHD youth may benefit from improving lifestyle choices such as increasing water consumption, decreasing screen time and getting at least one hour of physical activity per day. Mon, 02 May 2016 13:14:13 EDT https://www.sciencedaily.com/releases/2016/05/160502131413.htm